CORCEPT THERAPEUTICS INC (CORT) Net margin 2016–2025
CORCEPT THERAPEUTICS INC (CORT) net profit margin by fiscal year — reported net income divided by reported revenue.
13.1%FY2025 · since FY2016: 10.0% → 13.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 13.1% | -7.8 pp |
| FY2024 | 20.9% | -1.1 pp |
| FY2023 | 22.0% | -3.2 pp |
| FY2022 | 25.2% | -5.5 pp |
| FY2021 | 30.7% | +0.8 pp |
| FY2020 | 30.0% | -0.8 pp |
| FY2019 | 30.7% | +0.7 pp |
| FY2018 | 30.0% | -51.1 pp |
| FY2017 | 81.1% | +71.1 pp |
| FY2016 | 10.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice